Clinical Trial Update: Safety and Tolerability of Quetiapine in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and tolerability of quetiapine in patients with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED